ALEXA MEITZ: Open Payments
NPI 1255040788 · PINELLAS PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,095 in 95 payments from 20 companies in 2025. Trend: 2023 $597 · 2024 $1,092 · 2025 $2,095
Food & beverage: $2,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $461 |
| Madrigal Pharmaceuticals | 12 | $298 |
| Ardelyx, Inc. | 10 | $228 |
| QOL Medical, LLC | 6 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $157 |
| Janssen Biotech, Inc. | 5 | $141 |
| VIVUS LLC | 4 | $88 |
| PFIZER INC. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Novo Nordisk Inc | 3 | $72 |
Products named: REZDIFFRA, IBSRELA, Sucraid, RINVOQ, SKYRIZI, TREMFYA, ENTYVIO, DUPIXENT.
Industry payments across FL — which companies pay providers there.
